Everts V - Search Results

1

Tumor necrosis factor-α antagonist infliximab inhibits osteoclast formation of peripheral blood mononuclear cells but does not affect periodontal ligament fibroblast-mediated osteoclast formation.

de Vries TJ, Yousovich J, Schoenmaker T, Scheres N, Everts V. de Vries TJ, et al. Among authors: everts v. J Periodontal Res. 2016 Apr;51(2):186-95. doi: 10.1111/jre.12297. Epub 2015 Jun 12. J Periodontal Res. 2016. PMID: 26095433

2

Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts.

de Vries TJ, Schoenmaker T, Wattanaroonwong N, van den Hoonaard M, Nieuwenhuijse A, Beertsen W, Everts V. de Vries TJ, et al. Among authors: everts v. J Cell Biochem. 2006 May 15;98(2):370-82. doi: 10.1002/jcb.20795. J Cell Biochem. 2006. PMID: 16440316

3

Formation of osteoclast-like cells from peripheral blood of periodontitis patients occurs without supplementation of macrophage colony-stimulating factor.

Tjoa ST, de Vries TJ, Schoenmaker T, Kelder A, Loos BG, Everts V. Tjoa ST, et al. Among authors: everts v. J Clin Periodontol. 2008 Jul;35(7):568-75. doi: 10.1111/j.1600-051X.2008.01241.x. Epub 2008 Apr 23. J Clin Periodontol. 2008. PMID: 18435789

4

Direct cell-cell contact between periodontal ligament fibroblasts and osteoclast precursors synergistically increases the expression of genes related to osteoclastogenesis.

Bloemen V, Schoenmaker T, de Vries TJ, Everts V. Bloemen V, et al. Among authors: everts v. J Cell Physiol. 2010 Mar;222(3):565-73. doi: 10.1002/jcp.21971. J Cell Physiol. 2010. PMID: 19927302

5

Oestrogen inhibits osteoclast formation induced by periodontal ligament fibroblasts.

Wattanaroonwong N, Schoenmaker T, de Vries TJ, Everts V. Wattanaroonwong N, et al. Among authors: everts v. Arch Oral Biol. 2011 Mar;56(3):212-9. doi: 10.1016/j.archoralbio.2010.10.004. Epub 2010 Oct 28. Arch Oral Biol. 2011. PMID: 21035111

6

IL-1β favors osteoclastogenesis via supporting human periodontal ligament fibroblasts.

Bloemen V, Schoenmaker T, de Vries TJ, Everts V. Bloemen V, et al. Among authors: everts v. J Cell Biochem. 2011 Jul;112(7):1890-7. doi: 10.1002/jcb.23109. J Cell Biochem. 2011. PMID: 21433061

7

Diverse effects of Porphyromonas gingivalis on human osteoclast formation.

Scheres N, de Vries TJ, Brunner J, Crielaard W, Laine ML, Everts V. Scheres N, et al. Among authors: everts v. Microb Pathog. 2011 Sep;51(3):149-55. doi: 10.1016/j.micpath.2011.04.006. Epub 2011 Apr 27. Microb Pathog. 2011. PMID: 21539907

8

T cell-mediated increased osteoclast formation from peripheral blood as a mechanism for Crohn's disease-associated bone loss.

Oostlander AE, Everts V, Schoenmaker T, Bravenboer N, van Vliet SJ, van Bodegraven AA, Lips P, de Vries TJ. Oostlander AE, et al. Among authors: everts v. J Cell Biochem. 2012 Jan;113(1):260-8. doi: 10.1002/jcb.23352. J Cell Biochem. 2012. PMID: 21898548

9

A challenge with Porphyromonas gingivalis differentially affects the osteoclastogenesis potential of periodontal ligament fibroblasts from periodontitis patients and non-periodontitis donors.

Sokos D, Scheres N, Schoenmaker T, Everts V, de Vries TJ. Sokos D, et al. Among authors: everts v. J Clin Periodontol. 2014 Feb;41(2):95-103. doi: 10.1111/jcpe.12186. Epub 2013 Nov 19. J Clin Periodontol. 2014. PMID: 24164598

10

Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.

Sprangers S, Schoenmaker T, Cao Y, Everts V, de Vries TJ. Sprangers S, et al. Among authors: everts v. J Cell Physiol. 2016 Jun;231(6):1249-60. doi: 10.1002/jcp.25220. Epub 2015 Nov 9. J Cell Physiol. 2016. PMID: 26491867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters